News of Note—HPV vaccination, Imutex's universal flu shot and more

In this week's news of note, healthcare providers are found to recommend HPV vaccine more often to girls than boys. (Pixabay)

Here is some other vaccine news of note for the week:

> A recent study found that healthcare providers are not recommending HPV vaccination to boys as often as to girls. ABC News article

> British firm Imutex’s universal flu vaccine candidate Flu-v turned in positive clinical results and could be available on England's NHS in two years. Daily Mail article

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

THIS WEEK: Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today!

> Altimmune announced positive data from a phase 2a study of its monovalent NasoVAX intranasal flu vaccine. Results showed 100% seroprotection in the mid- and high-dose groups. Release

Suggested Articles

Find out how PDA can help you succeed with custom solutions and training for your employees – at your facility, our facility, or virtually.

Iowa State University is working on a room-temp-stable nasal spray vaccine for COVID-19, and it recently tapped device maker Zeteo for support.

Pfizer's shot will go before an FDA expert panel on Dec. 10, with Moderna's review pegged for the 17th, Warp Speed chief Moncef Slaoui, Ph.D., said.